AzTrials
AzTrials

Stress OxidativeNCT06895616

Effect of Baseline Cortisol Level on Lipid Peroxidation Products in Young Female Swimmers

An observational study of Stress Oxidative, run by Poznan University of Physical Education at 1 site in Poland.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Research group: twenty-four and homogeneous female swimmers, who train swimming intensively and attend the Sports Championship School Complex. In this cohort, baseline serum cortisol levels were considered, and the athletes were divided into two groups: 1) Serum cortisol <230 (normal): n=14 2) Serum cortisol >230… Read more about this study

Who is it for?
Ages 12 to 16 years, women only
Conditions the study is for
Stress Oxidative
How many people
24 participants
Where
1 sitePoland
Study dates
1 Mar 2023to 28 Dec 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 12 to 16 years
  • Women only
  • No healthy volunteers
  • Child

Study population: Swimmers attending the Sports Championship School Complex

Who may be able to join

  • valid medical examination,
  • consent of the legal guardian of the underage athlete to participate in the study,
  • Training experience a minimum of three years
  • Student of a sports championship school team,
  • ompletion of the exercise test in the swimming pool - crawl style intensive test (800 m + 200 m + 50 m) on two test deadline

Who cannot join

  • antibiotic therapy,
  • supplementation, use of any drugs or oral hormonal contraceptives
  • health problems within the last months

Trial locations and contacts

1 site in 1 country.

Poland1 site
  • Poznań University of Physical Education

    Poznan, 61-871

Other trials in Poland

About this study

Research group: twenty-four and homogeneous female swimmers, who train swimming intensively and attend the Sports Championship School Complex. In this cohort, baseline serum cortisol levels were considered, and the athletes were divided into two groups: 1) Serum cortisol <230 (normal): n=14 2) Serum cortisol >230 ng/ml (high): n=10

In this study, the athletes were subjected to intensive swimming tests in breaststroke crawl (800m + 200m + 50m) with 15 minutes of active rest between test sections in the water.

Blood samples took from the cubital vein at three time points: before stress test (pre-exercise), one minute after the end of the test (post-exercise), and after a 3-hour recovery period (3h recovery). Measurements morphology, 4-Hydroxynonenal (4-HNE), 8-isoprostane, cortysol levels were determined using ELISA kits.

Read the detailed description

The data of 24 trained female from the Sports Championship School Complex. All athletes presented as medically fit, with no underlying health problems. In this cohort, baseline serum cortisol levels were considered, and the athletes were divided into two groups: 1) Serum cortisol <230 (normal): n=14 2) Serum cortisol >230 ng/ml (high): n=10 In this study, the athletes were subjected to intensive swimming tests in breaststroke crawl (800m + 200m + 50m) with 15 minutes of active rest in the water. Blood samples took from the cubital vein at three time points: before stress test (pre-exercise), one minute after the end of the test (post-exercise), and after a 1-hour recovery period (3h recovery).

Measurement: All determined parameters were measured with the available equipment in the ZWKF laboratory in Gorzów Wielkopolski and using commercial assay kits. Measurements were performed by the project contractors.

  1. Polyethylene tubes (2.7ml) containing dipotassium ethylenediaminetetraacetic acid (EDTAK2) anticoagulant were used for the following tests: (a) complete blood count (7 parameters) determined on the MYTHIC 18 hematology analyzer (Orphee Medical, Geneva, Switzerland). Red blood cell indices: RBC (Red Blood Cells), HGB (Hemoglobin), HCT (Hematocrit), MCV (Mean Corpuscular Volume), MCH (Mean Corpuscular Hemoglobin), MCHC (Mean Corpuscular Hemoglobin Concentration), RDW (Red Blood cells Distribution Width). (b) a manual blood smear was made by placing a drop of blood on a slide and then spreading it with a uniform motion. After drying, it was colored by the May Grunwald-Giemsa method according to the procedure. The stained and fixed smear after drying was viewed under a microscope for quantitative and qualitative assessment.
  2. Polyethylene clotting activator tubes (9 ml) were centrifuged to separate the morphotic elements from the serum using a centrifuge (3000 rpm for 10 min). The serum was pipetted into several Eppendorf tubes, which then was frozen (temp. -80 °C). All the following biochemical parameters were determined from the extracted serum: (a) using the ELISA method by the test manufacturer's instructions. The designations include the flowing parameters:

4-Hydroxynonenal (4-HNE), 8-isoprostane, cortysol. (3) The lactate (La) concentration was determined from the capillary blood immediately after collection using a commercially available kit (Dr. Lange, Germany).

The athletes' diets were completely analyzed before each exercise test by a nutritionist. Participants, with the help of a dietician who was available during meals on test days, filled out food diaries. The amount of energy, protein, carbohydrates, fats and fiber were then analyzed using a commercially available program.

The experiment was conducted in accordance with the Declaration of Helsinki. The study protocol was approved by the Ethical Committee of the Medical University of Poznan

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Changes from baseline in 4-Hydroxynonenal (4-HNE) level.

    Concentration of 4-Hydroxynonenal (4-HNE) [pg/ml]. ELISA method by the test manufacturer's instructions

    Measured: At rest (before the test), directly after the test, and after a 3-hour recovery period.

  2. Changes from baseline in 8-isoprostane level.

    Concentration of 8-isoprostane [ng/mL]. ELISA method by the test manufacturer's instructions

    Measured: At rest (before the test), directly after the test, and after a 3-hour recovery period.

  3. Changes from baseline in Cortysol level.

    Concentration of cortysol [ng/mL]. ELISA method by the test manufacturer's instructions

    Measured: At rest (before the test), directly after the test, and after a 3-hour recovery period.

  4. a manual blood smear

    was made by placing a drop of blood on a slide and then spreading it with a uniform motion. After drying, it was colored by the May Grunwald-Giemsa method according to the procedure. The stained and fixed smear after drying was viewed under a microscope for quantitative and qualitative assessment.

    Measured: At rest (before the test), directly after the test, and after a 3-hour recovery period.

  5. complete blood count

    erythrocytes: RBC [10^6/mL], HGB [g/dL], HCT [%], MCV [mm^3], MCH [pg], MCHC [g/dL], RDW [%].

    Measured: At rest (before the test), directly after the test, and after a 3-hour recovery period.

Secondary outcomes (7)
  1. Antropometric characteristic - height

    Prior to the exercise test, the investigator measured the anthropometric parameters, including height (Seca 213 Hamburg, Deutschland) [cm]

    Measured: Day 1 after overall fast

  2. Antropometric characteristic - weight

    Prior to the exercise test, the investigator measured the anthropometric parameters, including weight (Tanita BC 418 MA, Tanita Corporation, Tokyo, Japan) [kg]

    Measured: Day 1 after overall fast

  3. Food record - energy

    Participants prepared a food record. The results were calculated using the dietetykpro program: energy [kcal]

    Measured: Day before the Day 1, in the morning at Day 1

  4. Food record - protein

    Participants prepared a food record. The results were calculated using the dietetykpro program: protein [kcal]

    Measured: Day before the Day 1, in the morning at Day 1

  5. Food record - carobhydrates

    Participants prepared a food record.The results were calculated using the dietetykpro program: carobhydrates [kcal]

    Measured: Day before the Day 1, in the morning at Day 1

  6. Food record - fiber

    Participants prepared a food record. The results were calculated using the dietetykpro program: fiber [kcal]

    Measured: Day before the Day 1, in the morning at Day 1

  7. Food record - fat

    Participants prepared a food record. The results were calculated using the dietetykpro program: fat [kcal]

    Measured: Day before the Day 1, in the morning at Day 1

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Mar 2025
  2. Study start1 Mar 2023
  3. Primary completion28 Dec 2023
  4. Study completion28 Dec 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
24 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06895616
Sponsor's protocol ID
SWIMMER- 2024
Status last verified
Mar 2025
First submitted
19 Mar 2025
Last updated
26 Mar 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Stress Oxidative, run by Poznan University of Physical Education at 1 site in Poland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 26 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Poland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Changes from baseline in 4-Hydroxynonenal (4-HNE) level. (time frame: At rest (before the test), directly after the test, and after a 3-hour recovery period.). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Mar 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in